Tag

Vaccine Ethics

All articles tagged with #vaccine ethics

Guinea-Bissau Police Seize Vaccines in Raid on US-Funded Trial
global-health4 hours ago

Guinea-Bissau Police Seize Vaccines in Raid on US-Funded Trial

Guinea-Bissau judicial police raided the offices of the Bandim Health Project on Monday, seizing doses of hepatitis B vaccine intended for a controversial clinical trial. The study, which would withhold birth-dose vaccines from 7,000 newborns, has been condemned as unethical by international health experts. Although the University of Southern Denmark approved the trial under budget pressure, Guinea-Bissau’s health minister denies authorizing it. The raid marks a significant escalation in a dispute involving US funding, Danish researchers, and local public health priorities.

CDC Allocates $1.6M to Revive Controversial Guinea-Bissau Vaccine Trial Amid Ethical Backlash
politics5 days ago

CDC Allocates $1.6M to Revive Controversial Guinea-Bissau Vaccine Trial Amid Ethical Backlash

The CDC has allocated $1.6 million to revive a controversial hepatitis B vaccine trial in Guinea-Bissau, despite international condemnation and a denial of approval from the host country’s health minister. The study, led by Danish researchers under investigation for misconduct, would withhold the birth dose from half of 14,000 newborns to test for alleged harms. Critics argue the rushed approval process, driven by expiring grant deadlines, compromised ethical safeguards and exposed vulnerable infants to preventable infection.

Danish University Approves Controversial Hepatitis B Trial in Guinea-Bissau Despite Ethical Protests
health-and-science11 days ago

Danish University Approves Controversial Hepatitis B Trial in Guinea-Bissau Despite Ethical Protests

The University of Southern Denmark has approved a controversial clinical trial in Guinea-Bissau that will withhold hepatitis B vaccines from half of 14,000 newborns. The study, funded by the US CDC and linked to HHS Secretary Robert F. Kennedy Jr., aims to test potential harms of the birth dose. Critics condemn the design as unethical, arguing it exposes vulnerable infants to preventable disease, while supporters note the country does not yet routinely vaccinate newborns. The trial remains suspended pending final government authorization in Guinea-Bissau.

CDC Allocates $1.6M to Revive Controversial Guinea-Bissau Vaccine Trial
health11 days ago

CDC Allocates $1.6M to Revive Controversial Guinea-Bissau Vaccine Trial

The CDC has moved to fund a previously suspended hepatitis B vaccine trial in Guinea-Bissau, allocating $1.6 million from global health security budgets. The study, led by Danish researchers under investigation for misconduct, would withhold the birth dose from half of 14,000 newborns. While the University of Southern Denmark has approved the revised protocol, the trial remains on hold pending final authorization from the Guinean government, drawing intense opposition from health experts and advocacy groups.

Ethics questions halt US-backed hepatitis B birth-vaccine trial in Guinea-Bissau
health9 months ago

Ethics questions halt US-backed hepatitis B birth-vaccine trial in Guinea-Bissau

An Africa CDC-backed US-funded birth-dose hepatitis B vaccine trial in Guinea-Bissau has been cancelled due to ethical concerns over its design; officials say it will only resume after a redesign to meet ethical norms, with ongoing talks between Guinea-Bissau and the US. Critics argued the trial could deprive thousands of children of vaccination for the sake of a coin-toss allocation, while supporters say it could improve access if properly implemented.